Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relevance of fluoroquinolone use in hospitals in the Lorraine region of France before and after corrective measures: an investigation by the Antibiolor Network.
Doco-Lecompte T, Demore B, Hénard S, Rughoo L, Burty C, Rondelot G, Frentiu E, Desmots E, Letranchant L, Robert C, Rabaud C, May T; French Antibiolor Network. Doco-Lecompte T, et al. Among authors: frentiu e. Scand J Infect Dis. 2012 Feb;44(2):86-92. doi: 10.3109/00365548.2011.616222. Epub 2011 Nov 10. Scand J Infect Dis. 2012. PMID: 22074400
[Two cases of spondylodiscitis due to Candida sp].
Frentiu E, Petitfrere M, May T, Rabaud C. Frentiu E, et al. Med Mal Infect. 2007 May;37(5):275-80. doi: 10.1016/j.medmal.2006.11.014. Epub 2007 Apr 24. Med Mal Infect. 2007. PMID: 17459637 French.
[Relevance of fluoroquinolone use in Lorraine: results of the first survey].
Doco-Lecompte T, Demoré B, Burty C, Rondelot G, Scheid P, Zuck P, Simon L, Letranchant L, Robert C, Frentiu E, Petitfrère M, Simplot B, Bevilacqua S, Voltz C, Rabaud C, May T; le réseau Antibiolor. Doco-Lecompte T, et al. Among authors: frentiu e. Med Mal Infect. 2010 Feb;40(2):106-11. doi: 10.1016/j.medmal.2009.08.022. Epub 2009 Oct 8. Med Mal Infect. 2010. PMID: 19818570 French.
Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting.
Deschanvres C, Reynes J, Lamaury I, Rey D, Palich R, Bani-Sadr F, Robineau O, Duvivier C, Hocqueloux L, Cuzin L, Joly V, Raffi F, Cabie A, Allavena C; Dat’AIDS Study Group. Deschanvres C, et al. J Antimicrob Chemother. 2021 Dec 24;77(1):196-204. doi: 10.1093/jac/dkab367. J Antimicrob Chemother. 2021. PMID: 34651192
No increased risk of Kaposi sarcoma relapse in patients with controlled HIV-1 infection after switching protease inhibitor-based antiretroviral therapy.
Lajaunie R, Cuzin L, Palich R, Makinson A, Bani-Sadr F, Duvivier C, Arvieux C, Rey D, Poizot-Martin I, Delpierre C, Delobel P, Martin-Blondel G; And The Dat’AIDS study group. Lajaunie R, et al. HIV Med. 2022 Mar;23(3):301-306. doi: 10.1111/hiv.13168. Epub 2021 Oct 19. HIV Med. 2022. PMID: 34668293 Free article.
16 results